Elkem Silicones
Develops AMSil™ silicone elastomer materials for additive manufacturing, enabling 3D printing of functional silicone parts with shore hardnesses 10-70 for medical, automotive, and industrial applications.
- Team Size
- 1001-5000
- Stage
- Public
- Total Funding
- Publicly Traded
- Key Investors
- Elkem ASA (parent company, listed Oslo Stock Exchange; being divested to China National Bluestar ~2026)
Technology & Products
Key Products
AMSil™ silicone elastomer materials for additive manufacturing, Silbione™ medical-grade silicones, Silcolapse™ silicone foam control agents, Puresil cosmetic solutions, and various silicone release coatings for papers and films.
Technological Advantage
Proprietary silicone formulations optimized for additive manufacturing processes, enabling high-density, functional parts with tailored properties (e.g., shore hardness, biocompatibility).
Differentiation
Value Proposition
Reduces lead times for silicone part prototyping and production from weeks to days, enables complex geometries impossible with traditional molding, and offers material customization (e.g., medical-grade, support materials) for functional applications.
How They Differentiate
Offers vertically integrated silicone production with AM-specific materials (AMSil™) vs. competitors' broader chemical portfolios; 30% lower carbon footprint in manufacturing; specialized support materials for 3D printing silicone.
Market & Competition
Target Customers
Manufacturers in medical, automotive, aerospace, and industrial sectors seeking high-performance, customizable silicone parts via 3D printing.
Industry Verticals
Medical; Automotive; Aerospace; Industrial; Consumer Goods
Competitors
Dow, Wacker Chemie AG, Shin-Etsu Chemical Co., Ltd.
Growth & Milestones
Growth Metrics
Revenue $1.7B in 2023; silicones division reported 177% earnings growth in 2021.
Major Milestones
Launched AMSil™ technology for 3D printing silicones (2021); Acquired Bluestar Silicones; Expanded to 27 production sites globally